Balanced crystalloid — Competitive Intelligence Brief

Balanced crystalloid (Balanced crystalloid) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid / Crystalloid solution. Area: Critical Care / Anesthesia / Emergency Medicine.

marketed Intravenous fluid / Crystalloid solution Critical Care / Anesthesia / Emergency Medicine Small molecule

Target snapshot

Balanced crystalloid (Balanced crystalloid) — National Taiwan University Hospital. Balanced crystalloid is an intravenous fluid solution that restores and maintains electrolyte and fluid balance in the body.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Balanced crystalloid TARGET	Balanced crystalloid	National Taiwan University Hospital	marketed	Intravenous fluid / Crystalloid solution
Dextrose 5% in water (D5W)	Dextrose 5% in water (D5W)	Hospital for Special Surgery, New York	marketed	Intravenous fluid / Crystalloid solution
Isotonic crystalloids	Isotonic crystalloids	Marie Kristine Jessen, MD	marketed	Intravenous fluid / Crystalloid solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid / Crystalloid solution class)

1. Hospital for Special Surgery, New York · 1 drug in this class
2. Marie Kristine Jessen, MD · 1 drug in this class
3. National Taiwan University Hospital · 1 drug in this class